(3-194) Treatment with Very Low Dose Nilotinib Due to Adverse Events Results in Prolonged Major Molecular Response

Monday, December 5, 2022

12:00 PM – 1:00 PM

Location: Bayside A, Level 1

Category: Case Report
Topic: Oncology/Hematology

Co-Author(s): Grady Upshaw, Jill Comeau, Richard Mansour

Primary Author(s)

Monica M. Whitman
Pharmacy Student
University of Louisiana Monroe College of Pharmacy, Louisiana